Cargando…

Animal Models of Molecular Pathology /

This volume explores some of the most exciting recent advances in basic research on animal models of molecular pathology.

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Conn, P. Michael (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London : Elsevier, 2012.
Colección:Progress in molecular biology and translational science ; v. 105.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Mi 4500
001 SCIDIR_ocn774290275
003 OCoLC
005 20231117044702.0
006 m o d
007 cr cn|||||||||
008 111221s2012 enkaf ob 001 0 eng d
040 |a E7B  |b eng  |e pn  |e rda  |c E7B  |d OPELS  |d N$T  |d CDX  |d YDXCP  |d OCLCQ  |d OCLCF  |d OCLCQ  |d UAB  |d MEU  |d OCLCQ  |d OL$  |d UKBTH  |d OCLCO  |d OCLCQ  |d OCLCO 
019 |a 1113790510 
020 |a 9780123945969  |q (electronic bk.) 
020 |a 0123945968  |q (electronic bk.) 
020 |a 9780123948311  |q (electronic bk.) 
020 |a 0123948312  |q (electronic bk.) 
020 |a 1283348055 
020 |a 9781283348058 
020 |a 9786613348050 
020 |a 6613348058 
035 |a (OCoLC)774290275  |z (OCoLC)1113790510 
050 4 |a RB113  |b .A55 2012eb 
072 7 |a SCI  |x 056000  |2 bisacsh 
082 0 4 |a 571.9/4  |2 23 
245 0 0 |a Animal Models of Molecular Pathology /  |c edited by P. Michael Conn. 
264 1 |a London :  |b Elsevier,  |c 2012. 
300 |a 1 online resource (xv, 454 pages, 8 unnumbered pages of plates) :  |b illustrations (some color). 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Progress in molecular biology and translational science,  |x 1877-1173 ;  |v v. 105 
546 |a Text in English. 
504 |a Includes bibliographical references and index. 
520 |a This volume explores some of the most exciting recent advances in basic research on animal models of molecular pathology. 
505 0 |a Front Cover; Animal Models of Molecular Pathology; Copyright; Contents; Contributors; Preface; Animal Models of Atherosclerosis; I. Atherosclerosis Development: Basic Concepts; II. Animal Models of Atherosclerosis; A. Rabbit Models of Atherosclerosis; B. Swine Models of Atherosclerosis; C. Nonhuman Primate Models of Atherosclerosis; D. Rodent Models of Atherosclerosis; III. Concluding Remarks; Acknowledgments; References; Genetic Animal Models of Cerebral Vasculopathies; I. Cerebral Amyloid Angiopathy; A. Clinical Overview; B. Molecular Biology; C. Animal Models for CAA 
505 8 |a D. Insights into Pathophysiology from Transgenic ModelsII. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL); A. Clinical Overview; B. Molecular Biology; C. Animal Models of CADASIL; a. R90C Mice; b. C428S Mice; c. R169C Mice; d. R142C Mice; e. R1031C and C455R; D. Insights into Pathophysiology from Transgenic Models; III. Concluding Remarks; Acknowledgments; References; Experimental Models of Seizures and Epilepsies; I. Introduction; II. Classification of Epileptic Seizures; A. Focal Onset Seizures; B. Generalized Onset Seizures 
505 8 |a C. Seizures of Unknown OriginIII. Classification of Epileptic Syndromes; IV. Models for Seizures and Epilepsies; A. The Perfect Animal Model; B. Chemical Models; C. Electrical Stimulation Models; D. Genetic Models; E. Developmental Models; F. Trauma Models; G. Emerging Epilepsy Models; V. Summary; References; Animal Models of Muscular Dystrophy; I. Dystrophin; A. Mouse Models for Duchenne Muscular Dystrophy; B. Canine Models for DMD; II. The Sarcoglycans; A. delta-Sarcoglycan and LGMD2F; B. gamma-Sarcoglycan and LGMD2C; C. beta-Sarcoglycan and LGMD2E; D. a-Sarcoglycan and LGMD2D 
505 8 |a E. Canine Models of Sarcoglycan DeficiencyIII. Calcium and Dystrophic Pathology; A. Calcium Contributes to the Pathology of Dystrophic Skeletal Muscles; B. Dysferlin Gene Mutations; C. Calpain 3 and LGMD2A; D. Titin and LGMD2J; IV. a-Actinin; V. Fukutin-Related Protein and Dystroglycan Processing; VI. Desmin; VII. Laminin a2; VIII. Collagen VI; IX. D4Z4 Repeats and FSHD; X. DMPK and Myotonic Dystrophy; XI. Conclusions; Acknowledgments; References; Acute Phase Proteins in Animals; I. The Acute Phase Response; A. Innate Immunity; B. Induction of the APR; C. Other Effects of the APR 
505 8 |a II. Acute Phase ProteinsA. C-Reactive Protein; B. Serum Amyloid A; C. Haptoglobin; D. Other APP; E. Negative Acute Phase Proteins; F. Quantitation of APP; III. Clinical Value of APP; A. Comparison to Other Markers of APR; B. Diagnosis; C. Prognosis; D. Subclinical Disease; E. Stress; F. Chronic Inflammation; IV. APP in Animals; A. Rodents and Rabbits; B. Companion Animals; C. Large Animals; D. Avian, Exotic, and Wildlife Species; V. Concluding Remarks; References; Animal Models of Hemophilia; I. The Hemophilia A Mice; A. Hemophilia A; B. The Hemophilia A Mouse Model 
650 0 |a Pathology, Molecular. 
650 2 |a Pathology, Molecular  |0 (DNLM)D057089 
650 6 |a Pathologie mol�eculaire.  |0 (CaQQLa)201-0062220 
650 7 |a SCIENCE  |x Life Sciences  |x Anatomy & Physiology.  |2 bisacsh 
650 7 |a Pathology, Molecular  |2 fast  |0 (OCoLC)fst01054980 
700 1 |a Conn, P. Michael,  |e editor. 
830 0 |a Progress in molecular biology and translational science ;  |v v. 105. 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780123945969  |z Texto completo